Wilsons disease) Active cancer or ongoing chemotherapy Severe liver or kidney disease Known hypersensitivity to copper peptides Drug interactions There are no well-established drug interaction studies for injectable GHK-Cu
Cagrilintide versus tirzepatide Tirzepatide produces the highest weight loss of currently approved medications, with trials showing 21 to 25% reduction over extended treatment periods
Use vitamin C serum in the morning before sunscreen
doi: 10.3389/fphar.2014.00196
Reduced glutathione (L-g-glutamyl-L-cysteinylglycine), a key antioxidant present in animals, plants, fungi and bacteria provides reducing equivalents in form of free thiol groups
Skin Rejuvenation Skin rejuvenation encompasses GHK-Cu's potential to reduce the signs of aging like wrinkles, fine lines, and age spots and improve skin texture and tone